Pfizer Inc. (NYSE:PFE)
Pfizer Inc. (NYSE:PFE), is a biopharmaceutical company. It discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments.
Forward PE:
PE multiples are widely available and represent what one share can buy for an equity investor. On October 28, 2015, the company was trading at a forward PE multiple of ~15.3x. Based on the multiple range over the last five years, Pfizer’s current valuation is neither high nor low. Over the past five years, Pfizer’s PE multiple has ranged from ~7x to ~16x, according to Market Realist.
Pfizer’s valuation multiple has also followed the industry’s overall trend for the last five years. Whether the healthcare sector’s forward PE multiple rises or falls, Pfizer will definitely be affected. The industry presently trades at a forward PE multiple of ~19.9x. Other competitors Johnson & Johnson (JNJ), Merck (MRK), and Eli Lilly (LLY) have forward PE multiples of 15.6x, 14.7x, and 23.0x, respectively. Market Realist Reports
Intercept Pharmaceuticals Inc (NASDAQ:ICPT)
On Thursday, Intercept Pharmaceuticals Inc (NASDAQ:ICPT)’s shares inclined -0.02% to $181.91.
ICPT has the market capitalization of $4.41 billion. The stock has P/B ratio of -6.04 while EPS was $-7.50. Institutional ownership of the company was 74.70% while 24.33 million shares were outstanding. Share of the company moved above its SMA 50 with 1.74%. ROE ratio was -39.20% while ROI was -49.00%.
The mean estimate for the short term price target for Intercept Pharmaceuticals Inc (ICPT) stands at $358.40 according to 15 Analysts. The higher price target estimate for the stock has been calculated at $515.00 while the lower price target estimate is at $110.00.
Analysts mean recommendation for the stock is 2.10. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Intercept Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics to treat chronic liver diseases utilizing its bile acid chemistry.
Opko Health Inc. (NYSE:OPK)
Opko Health Inc. (NYSE:OPK)’s shares gained 0.73% to $10.98.
OPK has market capitalization of $5.92 billion. Its current ratio was 1.50 while its shares were above its 50 days simple moving average with 14.14%. The company offered earning per share of $-0.23 while its 545.01 million shares were outstanding. YTD performance of the company was 9.91%. Stock volatility for the week was 4.69% while for the month it was shown at 5.06%.
The mean estimate for the short term price target for Opko Health Inc. (OPK) stands at $17.20 according to 5 Analysts. The higher price target estimate for the stock has been calculated at $22.00 while the lower price target estimate is at $11.00.
Analysts mean recommendation for the stock is 2.00. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
OPKO Health, Inc. (OPKO) is a biopharmaceutical and diagnostics company. The Company is involved in developing a range of solutions to diagnose, treat and prevent various conditions, including point-of-care tests, laboratory developed tests (LDTs), molecular diagnostics tests, and pharmaceuticals and vaccines.
Renren Inc (NYSE:RENN)
At the end of Thursday’s trade, Renren Inc (NYSE:RENN)‘s shares surged 1.85% to $3.57.
RENN Its past 5-day performance at -1.66% . So far in 2015, the company has a year-to-date performance of 42.23%. The stock, as of last close, traded 51.91% up from its 52 week low and was -19.78% below its 52 week high. Its latest closing price was 12.02% above the SMA200 while the distance from SMA 50 and SMA 20 was -9.46% and 1.46% respectively.
The mean estimate for the short term price target for Renren Inc (RENN) stands at $2.10 according to 1 Analysts. The higher price target estimate for the stock has been calculated at $2.10 while the lower price target estimate is at $2.10.
Analysts mean recommendation for the stock is -4.00. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Renren Inc. operates a real name social networking Internet platform in China. The Company enables users to connect and communicate with each other, share information and user generated content, play online games and enjoy a range of other features and services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.